This NIAAA grant supports research into prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan. The primary aim is to advance approaches that reduce prenatal alcohol exposure and FASD incidence, alongside developing effective interventions. Utilizing an Exploratory/Developmental Phased Award (R61/R33) mechanism, the R61 phase funds pilot studies or secondary data analysis for hypothesis development and feasibility. Successful achievement of R61 milestones, evaluated by NIAAA program staff, allows transition to the R33 phase for expanded hypothesis testing. Clinical trials are highly prioritized, though optional. This opportunity seeks to accelerate scientific understanding and practical solutions for FASD.
Opportunity ID: 357375
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-25-158 |
| Funding Opportunity Title: | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 25, 2024 |
| Last Updated Date: | Nov 25, 2024 |
| Original Closing Date for Applications: | Nov 17, 2026 |
| Current Closing Date for Applications: | Nov 17, 2026 |
| Archive Date: | Dec 23, 2026 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Native American tribal governments (Federally recognized) Small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public housing authorities/Indian housing authorities Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option). |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-158.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357375 Full Announcement-PAR-25-158 -> PAR-25-158-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288971 | Jan 19, 2025 | Nov 17, 2026 | View |
Package 1
Mandatory forms
357375 RR_SF424_5_0-5.0.pdf
357375 PHS398_CoverPageSupplement_5_0-5.0.pdf
357375 RR_OtherProjectInfo_1_4-1.4.pdf
357375 PerformanceSite_4_0-4.0.pdf
357375 RR_KeyPersonExpanded_4_0-4.0.pdf
357375 RR_Budget10_3_0-3.0.pdf
357375 PHS398_ResearchPlan_5_0-5.0.pdf
357375 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357375 RR_SubawardBudget10_30_3_0-3.0.pdf
357375 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
